This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Jim Cramer's 'Mad Money' Recap: Individual Stocks Rule

Stocks in this article: HSH MWV AAPL AGN VEEV MMP BAX BGG C PGH ADS JNJ ZMH SYK SNN MHR BRCM

When asked about those asset sales, Evans said that while the company's acres in Canada and in the Bakken shale were productive, in its core Marcellus and Utica acreage it has infrastructure available today and doesn't have to wait to get the oil and gas out to market.

When asked about converting some of the company's assets to a master limited partnership, or MLP, Evans said it is considering such a move for 2015 and estimate it could unlock $600 million to $700 million by creating a midstream MLP.

Finally, turning to production growth, Evans said Magnum is currently pumping 18,000 to 19,000 barrels a day but expects to see 32,000 barrels a day by the end of 2014.

Cramer said investors looking to add a speculative name to their portfolio should consider adding Magnum Hunter.

Cramer on J&J

Putting on his investment banker hat, Cramer offered some advice for the management of Johnson & Johnson (JNJ), an Action Alerts PLUS holding. He said that after Zimmer Holdings (ZMH) announced it's acquiring Biomet and Stryker (SYK) announced it's not buying Smith & Nephew (SNN), the only logical thing would be for Johnson & Johnson to buy Smith & Nephew.

Cramer said while he's pleased with J&J's 69% return over the past two years and its 2.9% yield, the company can certainly do even more for shareholders. He's already suggested the company follow in so many others' footsteps and break itself up in order to unlock value. Buying a company like Smith & Nephew would be almost as good.

Given the new competitive threat from Zimmer, Cramer said J&J needs to bulk up in the medical devices space and Smith & Nephew would certainly fit that bill. Since J&J has $29 billion in cash with most of that cash overseas, picking up the foreign-based Smith would be a perfect fit for tax reasons as well.

Executive Decision: Ed Heffernan

In his second "Executive Decision" segment, Cramer sat down with Ed Heffernan, president and CEO of Alliance Data Systems (ADS), the loyalty card purveyor that's seen its shares rise 544% over the past five years.

2 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs